$RMED The FDA dummies need to approve the 510(k) early next week so that we can get the fuck out of here. The company had $15m cash on Dec 31 ,2021 and I have a feeling they will do an offering soon given that they were allowed to expand their enrolment from 100 to 125 for their study. Considering the quarterly burn rate, I don't see how the available cash will be enough for the rest of the year. Best case scenario is a buyout but I think the company is still way off in their pipeline. A buyout would be amazing considering there's only 6.7m shares outstanding at the moment. Cash per share would be easily be in the range of $30. (Wife changing money)